<DOC>
	<DOCNO>NCT01330290</DOCNO>
	<brief_summary>The study objective evaluate advantage disadvantage Neupro® versus oral anti-Parkinson medication caregiver physicians idiopathic Parkinson 's Disease patient require caregiver support nursing home outpatient care setting .</brief_summary>
	<brief_title>Caregivers ' Physicians ' Treatment Preference Parkinson Patients Treated With Neupro® Requiring Caregiver Support</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Only patient sign consent form regard study information , data transfer data use The patient suffer idiopathic Parkinson 's Disease ( iPD ) treat combination Ldopa another oral iPD drug Neupro® least one month The patient require caregiver support document per medical record ( e.g . base German level care intensity 1 great ) The decision prescribe Neupro® must make physician independent his/her decision include patient study Patients fulfil inclusion criterion And accord Summary Product Characteristics ( SmPC ) : Hypersensitivity active substance excipients , magnetic resonance tomography ( MRT ) cardioversion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Rotigotine</keyword>
	<keyword>Neupro®</keyword>
	<keyword>Parkinson</keyword>
	<keyword>Treatment preference</keyword>
	<keyword>Care-giving</keyword>
</DOC>